Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Sales | 39,416 | 0 | 0 |
| Cost of Goods | 7,631 | N/A | N/A |
| Gross Profit | 31,785 | N/A | N/A |
| Operating Expenses | 35,951 | 0 | 0 |
| Operating Income | -3,535 | N/A | N/A |
| Interest Expense | 841 | 0 | 0 |
| Other Income | 111 | 0 | 0 |
| Pre-tax Income | -4,265 | 0 | 0 |
| Net Income Continuous | -4,265 | N/A | N/A |
| Net Income | $-4,265 | $N/A | $N/A |
| EPS Basic Total Ops | -0.13 | N/A | N/A |
| EPS Basic Continuous Ops | -0.12 | N/A | N/A |
| EPS Diluted Total Ops | -0.13 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.12 | N/A | N/A |
| EBITDA(a) | $-2,595 | $N/A | $N/A |